Oropharyngeal Cancer Archives - Cancer Therapy Advisor

HPV-Related Throat Cancer Outcomes in Men Vary by Race, Ethnicity

July 18, 2022

Non-Hispanic White men are less likely to die from HPV-related oropharyngeal cancer, when compared with Hispanic and non-Hispanic Black men.

Head and Neck Cancer

De-Escalation Strategy Produces ‘Favorable’ Outcomes in Oropharyngeal Carcinoma

By

Jonathan Goodman, MPhil

February 1, 2022

Reducing the radiotherapy dose and target volume to subclinical regions produced “favorable clinical outcomes,” according to researchers.

Head and Neck Cancer

Oropharyngeal Cancer Incidence, Mortality Up Among U.S. Men

December 29, 2021

The incidence of oropharyngeal cancer in men increased 2.7% per year.

Head and Neck Cancer

Incidence of Oropharyngeal Cancer Projected to Rise in U.S. Men

December 21, 2021

Under a status quo scenario based on current levels of HPV vaccination, 792,000 OPC cases in men would be prevented by the year 2100.

Head and Neck Cancer

Surgery Plus Radiotherapy Yields ‘Outstanding’ PFS in HPV+ Oropharyngeal Cancer

By

Sucharita Mistry, PhD

November 11, 2021

The 2-year progression-free survival rate exceeded 90% for all treatment arms.

Racial minorities are poorly represented in genomic research databases, raising important questions

Head and Neck Cancer

African-American Patients Have Worse Outcomes of Oropharyngeal Cancer Regardless of Access to Medical Care

By

Jayme Kunze, PA-C

June 9, 2021

Findings suggest a need for tailored treatment in oropharyngeal squamous cell carcinoma.

Head and Neck Cancer

Study Establishes Feasibility of Reduced-Dose IMRT Plus Cisplatin in Good-Risk HPV-Associated OPSCC

By

Leah Lawrence

February 9, 2021

Investigators tested the efficacy of reduced-dose radiation plus cisplatin in patients with good-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma (OPSCC).

Head and Neck Cancer

Factors Identified for Poor Long-Term Survival in RT-Treated Patients With Oropharyngeal Cancer

By

Susan Moench, PhD, PA-C

January 5, 2021

This analysis identified the factors for poor long-term survival in radiotherapy (RT)-treated patients with oropharyngeal cancer (OPC).

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis.

Head and Neck Cancer

Transoral Robotic Surgery Ups Survival in Oropharyngeal Cancer

August 25, 2020

Outcomes and survival improved for early-stage oropharyngeal cancer, but not other cancers.

Head and Neck Cancer

Weight and Swallowing-Related Quality of Life in Patients Treated for Oropharyngeal Cancer

By

Vicki Moore, PhD

August 21, 2020

Single-center study reports on the effects of oropharyngeal cancer treatment at 3, 6, and 12 months after chemoradiotherapy or radiotherapy alone, and with and without a feeding tube.